Skip to content
★ Sign in to follow
MB

Milton Boniuk

Executive
Nanoviricides, Inc.
Total declarations
61
Company
1
▲ Purchases (43 ops.)
€4.4M
▼ Sales (0 ops.)
—

Latest filing published 11 Oct 2018 for NANOVIRICIDES, INC..

Insider track record

Disclosed buys
43
Disclosed sells
0
Signal history

Closed purchases

Market purchases
43
Positive at T+90
33%
Median T+90
-11.8%

Based on 39 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 17 Nov 2015 · 4009 days ago · €28k
    +12.3%
    Entry US$22.80 · Close at T+365 US$25.60
  • Filed 23 Oct 2015 · 4034 days ago · €3,394
    +18.0%
    Entry US$25.60 · Close at T+365 US$30.20
  • Filed 15 Sept 2015 · 4072 days ago · €45k
    +32.2%
    Entry US$23.60 · Close at T+365 US$31.20
  • Filed 27 Aug 2015 · 4091 days ago · €46k
    +29.4%
    Entry US$23.80 · Close at T+365 US$30.80
  • Filed 25 Aug 2015 · 4093 days ago · €2,961
    +45.3%
    Entry US$21.20 · Close at T+365 US$30.80

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Milton Boniuk: trading record in brief

All filings by Milton Boniuk on record concern Nanoviricides, Inc. Between 12 September 2013 and 21 May 2018, the trades on record add up to 61 filings.

On the market, this insider has only ever bought: 43 purchases, €4.4M in total. The totals exclude 2 filings filed without an amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 15 share grants and 2 option exercises.

The median purchase comes to €36k. After 39 purchases with a full 90-day history, the hit rate stands at 33% and the median 90-day move at -11.8%. These figures describe past trades and do not predict future prices.

The record was last updated on 11 October 2018 with an option exercise in Nanoviricides, Inc. The latest purchase dates back some time: it was published 4,009 days ago, on 17 November 2015. Typically, a trade is published a median of 6 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Milton Boniuk

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations59 total
  • ◇
    10% OwnerExecutivesNanoviricides, Inc.
    0SEC
    5,500,000 sharesCommon Stock, par value $0.001 per shareSEC:0001214659-18-006488:4
  • ◇
    10% OwnerExecutivesNanoviricides, Inc.
    0SEC
    1,746,288 sharesCommon Stock, par value $0.001 per shareSEC:0001214659-18-006488:0
  • ◆
    10% OwnerExecutivesNanoviricides, Inc.
    0SEC
    153,611 sharesCommon Stock, par value $0.001 per shareSEC:0001214659-18-006488:1
  • ◆
    10% OwnerExecutivesNanoviricides, Inc.
    0SEC
    149,478 sharesCommon Stock, par value $0.001 per shareSEC:0001214659-18-006488:2
  • ◆
    10% OwnerExecutivesNanoviricides, Inc.
    0SEC
    120,744 sharesCommon Stock, par value $0.001 per shareSEC:0001214659-18-006488:3
  • ●
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    605,474 shares0Common Stock, par value $0.001 per shareSEC:0001144204-17-005838:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    37,500 USD13SEC
    25,000 shares@ US$1.5021.4% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-104385:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    25,185 USD12SEC
    14,991 shares@ US$1.6814.0% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-103281:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    37,500 USD13SEC
    25,000 shares@ US$1.5021.1% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-103281:1
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    11,943 USD12SEC
    7,109 shares@ US$1.686.7% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-099213:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    4,872 USD11SEC
    2,900 shares@ US$1.682.7% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-099213:1
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    44,500 USD14SEC
    25,000 shares@ US$1.7825.2% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-098303:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    15,300 USD12SEC
    9,000 shares@ US$1.708.8% of flowCommon Stock, par value $0.001 per shareSEC:0001144204-16-084125:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    9,000 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-16-082885:0
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    9,000 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-16-082885:1
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    34,043 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-16-082885:2
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    34,043 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-16-082885:3
  • ◆
    DirectorExecutivesNanoviricides, Inc.
    0SEC
    141,844 sharesCommon Stock, par value $0.001 per shareSEC:0001144204-16-082885:4
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    30,000 USD0SEC
    25,000 shares@ US$1.20Common Stock, par value $0.001 per shareSEC:0001144204-15-066271:0
    Canonical exit: 9 Feb 2016 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    2,860 USD0SEC
    2,200 shares@ US$1.30Common Stock, par value $0.001 per shareSEC:0001144204-15-060613:0
    Canonical exit: 13 Jan 2016 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    3,845 USD0SEC
    2,958 shares@ US$1.30Common Stock, par value $0.001 per shareSEC:0001144204-15-060613:1
    Canonical exit: 17 Jan 2016 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    6,763 USD0SEC
    5,202 shares@ US$1.30Common Stock, par value $0.001 per shareSEC:0001144204-15-060613:2
    Canonical exit: 19 Jan 2016 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    19,032 USD0SEC
    14,640 shares@ US$1.30Common Stock, par value $0.001 per shareSEC:0001144204-15-060613:3
    Canonical exit: 20 Jan 2016 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    51,000 USD0SEC
    50,000 shares@ US$1.02Common Stock, par value $0.001 per shareSEC:0001144204-15-055102:0
    Canonical exit: 10 Dec 2015 (T+90)
  • ▲
    DirectorExecutivesNanoviricides, Inc.
    52,500 USD0SEC
    50,000 shares@ US$1.05Common Stock, par value $0.001SEC:0001144204-15-052403:0
    Canonical exit: 24 Nov 2015 (T+90)

25 of 59 declarations